We are live on
!
Find out more
Fuller & Thaler Asset Management Portfolio holdings
AUM
$29.7B
1-Year Est. Return
43.33%
This Fund
S&P 500
This Quarter
Est. Return
-0.2%
1 Year Est. Return
+43.33%
3 Year Est. Return
+113.76%
5 Year Est. Return
+150.99%
10 Year Est. Return
+531.18%
AUM
$15.5B
AUM Growth
+$82.5M
(+0.54%)
Cap. Flow
+$344M
Cap. Flow
% of AUM
2.22%
Top 10 Holdings %
Top 10 Hldgs %
19.38%
Holding
566
New
30
Increased
170
Reduced
263
Closed
47
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Horizon
FHN
|
+$62.3M |
| 2 |
LHCG
LHC Group LLC
LHCG
|
+$49M |
| 3 |
The Ensign Group
ENSG
|
+$48.6M |
| 4 |
Exelixis
EXEL
|
+$47.2M |
| 5 |
EXL Service
EXLS
|
+$38.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVA
Covanta Holding Corporation
CVA
|
+$140M |
| 2 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$75.7M |
| 3 |
Ryman Hospitality Properties
RHP
|
+$32.7M |
| 4 |
VIVO
Meridian Bioscience Inc
VIVO
|
+$29.8M |
| 5 |
Celanese
CE
|
+$26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 27.19% |
| 2 | Industrials | 18.64% |
| 3 | Consumer Discretionary | 13.3% |
| 4 | Technology | 10.97% |
| 5 | Healthcare | 7.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Intel
INTC
$513B
| $1.45M | 0.01% |
27,275
-1,900
| -7% | -$103K |
|
377
Roper Technologies
ROP
$39.8B
| $1.42M | 0.01% |
3,175
+700
| +28% | +$335K |
|
378
Pinnacle West Capital
PNW
$12.2B
| $1.41M | 0.01% |
19,515
+4,700
| +32% | +$373K |
|
379
Morgan Stanley
MS
$340B
| $1.39M | 0.01% |
14,239
-1,000
| -7% | -$99.1K |
|
380
Globe Life
GL
$14.3B
| $1.38M | 0.01% |
15,500
+3,700
| +31% | +$346K |
|
381
Groupon
GRPN
$1.02B
| $1.37M | 0.01% |
60,015
-200
| -0.3% | -$5.91K |
|
382
T-Mobile US
TMUS
$190B
| $1.36M | 0.01% |
10,629
-700
| -6% | -$97.5K |
|
383
Centene
CNC
$32.5B
| $1.24M | 0.01% |
19,900
+4,800
| +32% | +$321K |
|
|
WBA
384
DELISTED
Walgreens Boots Alliance
WBA
| $1.24M | 0.01% |
26,271
-1,800
| -6% | -$86.8K |
|
|
KSU
385
DELISTED
Kansas City Southern
KSU
| $1.23M | 0.01% |
4,531
-8,445
| -65% | -$2.35M |
|
386
iShares Russell 2000 ETF
IWM
$81.9B
| $1.17M | 0.01% |
5,346
+3,952
| +284% | +$876K |
|
387
UGI
UGI
$7.33B
| $1.16M | 0.01% |
27,283
-3,372
| -11% | -$154K |
|
388
CMS Energy
CMS
$22.3B
| $1.14M | 0.01% |
19,100
+4,600
| +32% | +$287K |
|
389
Edison International
EIX
$26.4B
| $1.13M | 0.01% |
20,425
+4,900
| +32% | +$281K |
|
390
Biogen
BIIB
$30.7B
| $1.11M | 0.01% |
3,921
-300
| -7% | -$98.3K |
|
391
Limoneira
LMNR
$251M
| $1.01M | 0.01% |
62,255
-300
| -0.5% | -$5.05K |
|
392
Boston Scientific
BSX
$71.5B
| $962K | 0.01% |
22,160
-1,500
| -6% | -$66.4K |
|
393
J.M. Smucker
SJM
$12.8B
| $962K | 0.01% |
8,015
+1,800
| +29% | +$229K |
|
394
Live Oak Bancshares
LOB
$1.97B
| $908K | 0.01% |
14,266
-650
| -4% | -$38.5K |
|
|
NLSN
395
DELISTED
Nielsen Holdings plc
NLSN
| $888K | 0.01% |
46,255
+11,200
| +32% | +$249K |
|
396
Carnival Corporation Ltd
CCL
$39.7B
| $886K | 0.01% |
35,417
-2,300
| -6% | -$53.5K |
|
397
Idexx Laboratories
IDXX
$46.2B
| $882K | 0.01% |
1,418
-100
| -7% | -$67.2K |
|
398
Humana
HUM
$46.2B
| $821K | 0.01% |
2,110
-100
| -5% | -$42.4K |
|
|
EVFM
399
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $798K | 0.01% |
+71,991
| New | +$905K |
|
400
iShares Russell 2000 Growth ETF
IWO
$15B
| $782K | 0.01% |
2,663
+363
| +16% | +$109K |
|
Similar funds
Fuller & Thaler Asset Management's Q3 2021 Portfolio in Review
As of Q3 2021, Fuller & Thaler Asset Management held 566 positions worth $15.5B, up 0.54% from $15.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Fuller & Thaler Asset Management's Q3 2021 filing shows 30 new, 170 increased, 263 reduced and 47 closed positions. Its largest new stake was LHC Group LLC: 261,044 shares worth $41M. The largest sale was Covanta Holding Corporation, an estimated $140M.
By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 26% a quarter earlier, followed by Industrials and Consumer Discretionary.
- Fuller & Thaler Asset Management's largest Q3 2021 buy was LHC Group LLC: 261,044 shares worth $41M.
- Fuller & Thaler Asset Management added most to First Horizon in Q3 2021, an estimated $62.3M increase.
- Fuller & Thaler Asset Management's biggest Q3 2021 reduction was Covanta Holding Corporation, cutting an estimated $140M.
- Fuller & Thaler Asset Management fully exited PRA Health Sciences, Inc. in Q3 2021, selling an estimated $75.7M.
- Fuller & Thaler Asset Management's ten largest holdings make up 19% of its $15.5B portfolio in Q3 2021.
- Fuller & Thaler Asset Management opened 30 new positions and closed 47 in Q3 2021.
- Fuller & Thaler Asset Management's portfolio value rose 0.54% quarter-over-quarter to $15.5B.
Based on Fuller & Thaler Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.